Rasenack, Jens; Zeuzem, Stefan; Feinman, S. Victor; … - In: PharmacoEconomics 21 (2003) 5, pp. 341-349
-related quality of life during therapy. Treatment with peginterferon alpha-2a (40kD) provides an improved sustained response over … unmodified interferon alpha-2a. Objectives: To compare health-related quality of life during treatment for patients receiving … interferon alpha-2a. In addition to safety and efficacy, the impact on health-related quality of life may be an important …